Antimalaria drug hydroxychloroquine proved no better than a placebo in preventing Covid-19 in people who had been exposed to the coronavirus, according to a new study
Hydroxychloroquine proved no better than a placebo in preventing Covid-19 in people who had been exposed to the coronavirus, according to study in the New England Journal of Medicine
As the coronavirus continues to spread around the globe, companies and academic labs are racing to develop a vaccine that would help society get back to normal. But there could also be costs to moving too quickly. WSJ’s Daniela Hernandez explains. Photo illustration: Laura Kammermann
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Malaria drug touted by Trump ineffective to prevent COVID-19 in high profile studyThe new trial found no serious side effects or heart problems from use of hydroxychloroquine. In the first major study comparing hydroxychloroquine to a placebo to gauge its effect against the new coronavirus, University of Minnesota researchers tested 821 people who had recently been exposed to the
続きを読む »
'Often mistrusted': UK stats watchdog slams Covid-19 test data'The aim seems to be to show the largest possible number of tests even at the expense of understanding.' David Norgrove of UK Statistics Authority criticises British government's Covid19 test data
続きを読む »
Why Wearing Gloves To The Grocery Store Won't Protect You From COVID-19The key way to avoid infection is by sanitizing your hands regularly and not touching your face.
続きを読む »
Tesla could have an edge over rivals during COVID-19, expert says - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
続きを読む »
Why are Britons reluctant to wear masks to contain covid-19?Mask-phobic countries have fared worse in the pandemic than mask-loving ones
続きを読む »